FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Beclomenthasone Dipropionate HFA Inhalation Aerosol
Status: Discontinuation
»Therapeutic Categories:

Teva Pharmaceuticals (New 08/16/2017)

Company Contact Information:

Presentation Posting Date Related Information
Beclomethasone Diproprionate HFA Inhalation Aerosol 40 mcg and 80 mcg, (NDC 59310-202-12), (NDC 59310-204-12) 08/16/2017 The company has made a business decision to discontinue manufacturing of the product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English